These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 24727473)
1. Multiple glycosaminoglycan-binding epitopes of monocyte chemoattractant protein-3/CCL7 enable it to function as a non-oligomerizing chemokine. Salanga CL; Dyer DP; Kiselar JG; Gupta S; Chance MR; Handel TM J Biol Chem; 2014 May; 289(21):14896-912. PubMed ID: 24727473 [TBL] [Abstract][Full Text] [Related]
2. The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization. Dyer DP; Salanga CL; Volkman BF; Kawamura T; Handel TM Glycobiology; 2016 Mar; 26(3):312-26. PubMed ID: 26582609 [TBL] [Abstract][Full Text] [Related]
3. Designing a mutant CCL2-HSA chimera with high glycosaminoglycan-binding affinity and selectivity. Gerlza T; Winkler S; Atlic A; Zankl C; Konya V; Kitic N; Strutzmann E; Knebl K; Adage T; Heinemann A; Weis R; Kungl AJ Protein Eng Des Sel; 2015 Aug; 28(8):231-40. PubMed ID: 25969511 [TBL] [Abstract][Full Text] [Related]
4. Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo. Lau EK; Paavola CD; Johnson Z; Gaudry JP; Geretti E; Borlat F; Kungl AJ; Proudfoot AE; Handel TM J Biol Chem; 2004 May; 279(21):22294-305. PubMed ID: 15033992 [TBL] [Abstract][Full Text] [Related]
5. Chemokine-glycosaminoglycan binding: specificity for CCR2 ligand binding to highly sulfated oligosaccharides using FTICR mass spectrometry. Yu Y; Sweeney MD; Saad OM; Crown SE; Hsu AR; Handel TM; Leary JA J Biol Chem; 2005 Sep; 280(37):32200-8. PubMed ID: 16033763 [TBL] [Abstract][Full Text] [Related]
6. A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammation. Ali S; Robertson H; Wain JH; Isaacs JD; Malik G; Kirby JA J Immunol; 2005 Jul; 175(2):1257-66. PubMed ID: 16002730 [TBL] [Abstract][Full Text] [Related]
7. The Anti-inflammatory Protein TSG-6 Regulates Chemokine Function by Inhibiting Chemokine/Glycosaminoglycan Interactions. Dyer DP; Salanga CL; Johns SC; Valdambrini E; Fuster MM; Milner CM; Day AJ; Handel TM J Biol Chem; 2016 Jun; 291(24):12627-12640. PubMed ID: 27044744 [TBL] [Abstract][Full Text] [Related]
8. Key determinants of selective binding and activation by the monocyte chemoattractant proteins at the chemokine receptor CCR2. Huma ZE; Sanchez J; Lim HD; Bridgford JL; Huang C; Parker BJ; Pazhamalil JG; Porebski BT; Pfleger KDG; Lane JR; Canals M; Stone MJ Sci Signal; 2017 May; 10(480):. PubMed ID: 28536301 [TBL] [Abstract][Full Text] [Related]
10. Dissecting the differential structural and dynamics features of CCL2 chemokine orthologs. Joshi N; Nagar N; Gulati K; Gangele K; Mishra A; Kumar D; Poluri KM Int J Biol Macromol; 2020 Aug; 156():239-251. PubMed ID: 32289428 [TBL] [Abstract][Full Text] [Related]
11. Potential inhibitors of chemokine function: analysis of noncovalent complexes of CC chemokine and small polyanionic molecules by ESI FT-ICR mass spectrometry. Yu Y; Sweeney MD; Saad OM; Leary JA J Am Soc Mass Spectrom; 2006 Apr; 17(4):524-535. PubMed ID: 16503157 [TBL] [Abstract][Full Text] [Related]
12. The beta-chemokines CCL2 and CCL7 are two novel differentiation factors for midbrain dopaminergic precursors and neurons. Edman LC; Mira H; Arenas E Exp Cell Res; 2008 Jun; 314(10):2123-30. PubMed ID: 18420193 [TBL] [Abstract][Full Text] [Related]
13. An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo. Handel TM; Johnson Z; Rodrigues DH; Dos Santos AC; Cirillo R; Muzio V; Riva S; Mack M; Déruaz M; Borlat F; Vitte PA; Wells TN; Teixeira MM; Proudfoot AE J Leukoc Biol; 2008 Oct; 84(4):1101-8. PubMed ID: 18662971 [TBL] [Abstract][Full Text] [Related]
14. Multimerization of monocyte chemoattractant protein-1 is not required for glycosaminoglycan-dependent transendothelial chemotaxis. Ali S; Palmer AC; Fritchley SJ; Maley Y; Kirby JA Biochem J; 2001 Sep; 358(Pt 3):737-45. PubMed ID: 11535134 [TBL] [Abstract][Full Text] [Related]
15. The CCL2/CCL7/CCL12/CCR2 pathway is substantially and persistently upregulated in mice after traumatic brain injury, and CCL2 modulates the complement system in microglia. Popiolek-Barczyk K; Ciechanowska A; Ciapała K; Pawlik K; Oggioni M; Mercurio D; De Simoni MG; Mika J Mol Cell Probes; 2020 Dec; 54():101671. PubMed ID: 33160071 [TBL] [Abstract][Full Text] [Related]
16. Rationally evolving MCP-1/CCL2 into a decoy protein with potent anti-inflammatory activity in vivo. Piccinini AM; Knebl K; Rek A; Wildner G; Diedrichs-Möhring M; Kungl AJ J Biol Chem; 2010 Mar; 285(12):8782-92. PubMed ID: 20097750 [TBL] [Abstract][Full Text] [Related]
17. Structural characterization of a monomeric chemokine: monocyte chemoattractant protein-3. Kim KS; Rajarathnam K; Clark-Lewis I; Sykes BD FEBS Lett; 1996 Oct; 395(2-3):277-82. PubMed ID: 8898111 [TBL] [Abstract][Full Text] [Related]
18. Lysine 58 and histidine 66 at the C-terminal alpha-helix of monocyte chemoattractant protein-1 are essential for glycosaminoglycan binding. Chakravarty L; Rogers L; Quach T; Breckenridge S; Kolattukudy PE J Biol Chem; 1998 Nov; 273(45):29641-7. PubMed ID: 9792674 [TBL] [Abstract][Full Text] [Related]
19. Differential Roles of Chemokines CCL2 and CCL7 in Monocytosis and Leukocyte Migration during West Nile Virus Infection. Bardina SV; Michlmayr D; Hoffman KW; Obara CJ; Sum J; Charo IF; Lu W; Pletnev AG; Lim JK J Immunol; 2015 Nov; 195(9):4306-18. PubMed ID: 26401006 [TBL] [Abstract][Full Text] [Related]
20. Differentiation of CC vs CXC chemokine dimers with GAG octasaccharide binding partners: an ion mobility mass spectrometry approach. Seo Y; Andaya A; Bleiholder C; Leary JA J Am Chem Soc; 2013 Mar; 135(11):4325-32. PubMed ID: 23418647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]